Literature DB >> 27012840

Validation of rapid suicidality screening in epilepsy using the NDDIE.

Marco Mula1,2,3, Aileen McGonigal4,5, Jean-Arthur Micoulaud-Franchi6,7, Theodor W May8, Kirsten Labudda9,10, Christian Brandt10.   

Abstract

OBJECTIVE: Standard mortality ratio for suicide in patients with epilepsy is three times higher than in the general population, and such a risk remains high even after adjusting for clinical and socioeconomic factors. It is thus important to have suitable screening instruments and to implement care pathways for suicide prevention in every epilepsy center. The aim of this study is to validate the use of the Neurological Disorder Depression Inventory for Epilepsy (NDDIE) as a suicidality-screening instrument.
METHODS: The study sample included adult patients with epilepsy assessed with the Mini International Neuropsychiatric Interview (MINI) and the NDDIE. A high suicidality risk according to the Suicidality Module of the MINI was considered the gold standard. Receiver operating characteristic analyses for NDDIE total and individual item scores were computed and subsequently compared using a nonparametric approach. The best possible cutoff was identified with the highest Youden index (J). Likelihood ratios were then computed, and specificity, sensitivity, positive, and negative predictive values calculated.
RESULTS: The study sample consisted of 380 adult patients with epilepsy: 46.3% male; mean age was 39.4 ± 14.6; 76.7% had a diagnosis of focal epilepsy; mean age at onset of the epilepsy was 23.3 ± 17.5. According to the MINI, 74 patients (19.5%) fulfilled criteria for a major depressive episode and 19 (5%) presented a high suicidality risk. A score >2 (J = 0.751) for item 4 "I'd be better off dead" of the NDDIE displayed excellent psychometric properties with a good to excellent validity (area under the curve [AUC] 0.906; 95% confidence interval [CI] 0.820-0.992; p < 0.001), sensitivity 84.21% (95% CI 60.4-96.6), specificity 90.86% (95% CI 87.4-93.6), likelihood ratio+ 9.21 (95% CI 6.3-13.5), likelihood ratio- 0.17 (95% CI 0.06-0.50). SIGNIFICANCE: Item 4 of the NDDIE has shown to be an excellent suicidality screening instrument allowing the development of further care pathways for suicide prevention in epilepsy centers. Wiley Periodicals, Inc.
© 2016 International League Against Epilepsy.

Entities:  

Keywords:  Depression; Epilepsy; NDDIE; Screening; Suicide

Mesh:

Year:  2016        PMID: 27012840     DOI: 10.1111/epi.13373

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  8 in total

1.  Who is willing to participate in research? A screening model for an anxiety and depression trial in the epilepsy clinic.

Authors:  Heidi M Munger Clary; Rachel D Croxton; Jonathan Allan; James Lovato; Gretchen Brenes; Beverly M Snively; Mingyu Wan; James Kimball; Matthew H Wong; Cormac A O'Donovan; Kelly Conner; Victor Jones; Pamela Duncan
Journal:  Epilepsy Behav       Date:  2020-01-27       Impact factor: 2.937

Review 2.  Should adult neurologists play a role in the management of the most common psychiatric comorbidities? Practical considerations.

Authors:  Heidi M Munger Clary; Jay A Salpekar
Journal:  Epilepsy Behav       Date:  2018-11-22       Impact factor: 2.937

Review 3.  Suicide and Epilepsy.

Authors:  Luciana Giambarberi; Heidi M Munger Clary
Journal:  Curr Neurol Neurosci Rep       Date:  2022-06-17       Impact factor: 6.030

Review 4.  Psychiatric Comorbidities in People With Epilepsy.

Authors:  Marco Mula; Andres M Kanner; Nathalie Jetté; Josemir W Sander
Journal:  Neurol Clin Pract       Date:  2021-04

5.  Patient-reported outcomes via electronic health record portal versus telephone: a pragmatic randomized pilot trial of anxiety or depression symptoms in epilepsy.

Authors:  Heidi M Munger Clary; Beverly M Snively; Umit Topaloglu; Pamela Duncan; James Kimball; Halley Alexander; Gretchen A Brenes
Journal:  JAMIA Open       Date:  2022-10-12

6.  Neurologist prescribing versus psychiatry referral: Examining patient preferences for anxiety and depression management in a symptomatic epilepsy clinic sample.

Authors:  Heidi M Munger Clary; Rachel D Croxton; Beverly M Snively; Gretchen A Brenes; James Lovato; Fatemeh Sadeghifar; James Kimball; Cormac O'Donovan; Kelly Conner; Esther Kim; Jonathan Allan; Pamela Duncan
Journal:  Epilepsy Behav       Date:  2020-11-24       Impact factor: 2.937

7.  Managing depression and anxiety in people with epilepsy: A survey of epilepsy health professionals by the ILAE Psychology Task Force.

Authors:  Milena Gandy; Avani C Modi; Janelle L Wagner; W Curt LaFrance; Markus Reuber; Venus Tang; Kette D Valente; Laura H Goldstein; Kirsten A Donald; Genevieve Rayner; Rosa Michaelis
Journal:  Epilepsia Open       Date:  2021-02-08

Review 8.  Would people living with epilepsy benefit from palliative care?

Authors:  Benzi M Kluger; Cornelia Drees; Thomas R Wodushek; Lauren Frey; Laura Strom; Mesha-Gay Brown; Jacquelyn L Bainbridge; Sarah N Fischer; Archana Shrestha; Mark Spitz
Journal:  Epilepsy Behav       Date:  2020-11-24       Impact factor: 3.337

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.